Clinical Study of the Solo+ Tympanostomy Tube Device

NAActive, not recruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 9, 2021

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Ear InfectionOtitis Media
Interventions
DEVICE

Solo+ Tympanostomy Tube Device

The Solo+ Tympanostomy Tube Device is intended to deliver a tympanostomy tube through the tympanic membrane of a patient during a tympanostomy procedure

Trial Locations (2)

20010

Children's National Medical Center, Washington D.C.

53226

Children's Hospital of Wisconsin, Milwaukee

All Listed Sponsors
lead

AventaMed DAC

INDUSTRY